Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Modica

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Heart Journal|September 1, 2024
Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registryJessica Schubert, Margrét Leosdottir, Bertil Lindahl, et al.
BMJ Open|January 12, 2024
Randomised, siteless study to compare systematic atrial fibrillation screening using enrichment by a risk prediction model with standard care in a Swedish population aged ≥ 65 years: CONSIDERING-AF study designFarzaneh Etminani, Emma Sandgren, Johan Holm, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 22, 2025
Systematic, randomised atrial fibrillation screening using detailed phenotyping with a risk-prediction model combined with patch electrocardiogram in a Swedish population aged 65 years or older: The CONSIDERING-AF trialEmelie Rakai, Farzaneh Etminani, Ninia Younan, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Heart Journal|September 1, 2024
Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registryJessica Schubert, Margrét Leosdottir, Bertil Lindahl, et al.
BMJ Open|January 12, 2024
Randomised, siteless study to compare systematic atrial fibrillation screening using enrichment by a risk prediction model with standard care in a Swedish population aged ≥ 65 years: CONSIDERING-AF study designFarzaneh Etminani, Emma Sandgren, Johan Holm, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 22, 2025
Systematic, randomised atrial fibrillation screening using detailed phenotyping with a risk-prediction model combined with patch electrocardiogram in a Swedish population aged 65 years or older: The CONSIDERING-AF trialEmelie Rakai, Farzaneh Etminani, Ninia Younan, et al.
Pageof 2